Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1964 1
1965 1
1968 1
1981 4
1982 4
1983 7
1984 9
1985 11
1986 11
1987 13
1988 13
1989 11
1990 14
1991 23
1992 25
1993 28
1994 32
1995 29
1996 30
1997 32
1998 25
1999 30
2000 29
2001 58
2002 57
2003 87
2004 114
2005 117
2006 154
2007 179
2008 179
2009 231
2010 260
2011 316
2012 412
2013 501
2014 571
2015 648
2016 658
2017 700
2018 768
2019 884
2020 1131
2021 1306
2022 1513
2023 1608
2024 1858
2025 2117
2026 1088

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,082 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.
Xiong A, Yao W, Zheng W, Yu Y, Chen P, Zhong H, Ge J, Wang H, Chen B, Wang H, Fan Y, Yang Y, Pu X, Song X, Wang Q, Du X, Huang Z, Li X, Luo H, Yao Y, Yu Q, Su C, He L, Jiang G, Cui J, Liu C, Yi T, Che G, Liu Z, Zhang L, Zhou M, Fang Y, Wei Y, Qing Y, Jin X, Zhou C. Xiong A, et al. Among authors: luo h. Lancet. 2026 May 29:S0140-6736(26)00968-2. doi: 10.1016/S0140-6736(26)00968-2. Online ahead of print. Lancet. 2026. PMID: 42214392
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Lu S, Liu B, Luo Y, Sun L, Wu L, Han Z, Fan Y, Zhao Y, Li X, Xu H, Meng X, Liu Y, Zhang Z, Luo H, Ma X, Ma X, Shi Q, Zhang Z, Yang R, Wang P, Pan P, Ai X, Li J, Pu X, Wang Z, Fang J, He M, He Y, Guo S, Li J, Wang H, Zhang J, Chu Q, Liu X, Ying S, Wu H, Sun H, Ji Y, Zhou M, Cao C, Tang K, Li Z, Li D, Zhang Z, Li J, Zhou J, Yang H, Du Y, Yang H, Shi J, Chen H, Chen Z, Li W, Lu D, Hu M, Wang ZM, Li B, Xia MY. Lu S, et al. Among authors: luo h. Lancet. 2026 May 31:S0140-6736(26)00966-9. doi: 10.1016/S0140-6736(26)00966-9. Online ahead of print. Lancet. 2026. PMID: 42218899
Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma.
Lin Y, Peng L, Zhao H, Lin P, Chen L, Gong Z, Lin J, Liu D, Yang X, Song X, Zhang M, Ji S, Rao J, Luo H, Cheng Y, Chen X, Song G, Hou H, Rao D, Zhang T, Liu W, Zhang S, Xu G, Zhang J, Xiao L, Liang Y, Liu Y, Chen Y, Cui Z, Wang X, Zhou J, Gao Q, Wu K, Fan J. Lin Y, et al. Among authors: luo h. Cell Rep Med. 2026 Apr 21;7(4):102708. doi: 10.1016/j.xcrm.2026.102708. Epub 2026 Mar 30. Cell Rep Med. 2026. PMID: 41916296 Free PMC article.
A non-invasive end-to-end intelligent assistance system for breast ultrasound.
Zhou J, Si P, Zhang Y, Song J, He T, Liu Q, Chen S, Tu M, Wang H, Guo Q, Qi X, Zhang D, Zhang Q, Zhang T, Pan L, Li S, Tang Z, Guo J, Lan H, Li X, Tang Y, Tang M, Shen Q, Luo H, Lang Z, Hu X, Du H, Tian R, Yang X, Gan X, Chen F, Liu X, Zhang W, Xie Q, Zhang J, Yang H, Yang X, Kang Y, Xiong M, Zhang Y, Liu H, Wan M, Xiong Y, Li T, Zhao C, Zhao H, Cui X, Yi Z, Zeng F. Zhou J, et al. Among authors: luo h. Nat Commun. 2026 May 20. doi: 10.1038/s41467-026-73170-5. Online ahead of print. Nat Commun. 2026. PMID: 42161976 Free article.
Genetic factors contributing to viral myocarditis.
Wang Z, Mohamud Y, Luo H. Wang Z, et al. Among authors: luo h. Microbiol Mol Biol Rev. 2026 Apr 20:e0035725. doi: 10.1128/mmbr.00357-25. Online ahead of print. Microbiol Mol Biol Rev. 2026. PMID: 42007711 Review.
Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.
Ma X, Ma Y, Zhang L, Liu R, Xia R, Hao M, Song X, Chen Y, Zheng Y, Wang H, Luo H, Zheng S, Yang J, Yang Q, Jiang R, Chen X, Hou P, Hui K, Bian Q, Jiang B, Jiang X, Jiang M, Zhang Y, Shain AH, Ren G, Lei M, Judson-Torres RL, Guo W, Zeng H. Ma X, et al. Among authors: luo h. Sci Adv. 2026 Apr 3;12(14):eady4536. doi: 10.1126/sciadv.ady4536. Epub 2026 Apr 1. Sci Adv. 2026. PMID: 41920996 Free PMC article.
16,082 results
You have reached the last available page of results. Please see the User Guide for more information.